XENON PHARMACEUTICALS INC. Employee Count
The employee counts XENON PHARMACEUTICALS INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 370; Filing 2026-02-26; Lease expense per employee $6,672.97.
- 2024-12-31: Employees (as filed) 327; Filing 2025-02-27; Lease expense per employee $7,559.63.
- 2023-12-31: Employees (as filed) 259; Filing 2024-02-29; Lease expense per employee $9,389.96.
- 2022-12-31: Employees (as filed) 213; Filing 2023-03-01; Lease expense per employee $8,920.19.
- Available history
- 2019-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 370 full-time | 2026-02-26 | $6,672.97 operating + variable |
| 2024-12-31 | 327 full-time | 2025-02-27 | $7,559.63 operating + variable |
| 2023-12-31 | 259 full-time | 2024-02-29 | $9,389.96 operating + variable |
| 2022-12-31 | 213 full-time | 2023-03-01 | $8,920.19 operating + variable |
| 2021-12-31 | 153 full-time | 2022-03-01 | $8,771.24 operating + variable |
| 2020-12-31 | 129 full-time | 2021-03-01 | $8,410.85 operating + variable |
| 2019-12-31 | 104 full-time | 2020-03-09 | $9,403.85 operating + variable |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |